Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative CT-scan to evaluate cerebral edema secondary to hyperammonemia in ICU: A proof-of-concept study.

Journal of intensive medicine·2026
Same author

Bispecific antibody therapy in multiple myeloma and risk of progressive multifocal leukoencephalopathy.

Blood advances·2026
Same author

Cyclic Recurrence of Seizures as a Marker for Super-Refractory Status Epilepticus.

Brain and behavior·2026
Same author

Development and preclinical evaluation of a hybrid stereoelectroencephalographic-laser depth electrode for magnetic resonance imaging-guided interstitial thermal therapy in drug-resistant epilepsy.

Epilepsia·2026
Same author

Stepwise clinical and diagnostic strategy for coma of unknown origin.

Intensive care medicine·2026
Same author

Neurological outcome of patients with a non-traumatic infratentorial cerebellar haematoma admitted to the intensive care unit.

Anaesthesia and intensive care·2026

Related Experiment Video

Updated: Jun 24, 2026

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

Gabapentin-induced coma: A MR-spectrometry analysis.

Lamine Abdennour1, Paola Sanchez-Peña, Damien Galanaud

  • 1Staff Anesthesiologist, Department of Anesthesiology and Critical Care.

Neuropsychiatric Disease and Treatment
|March 21, 2009
PubMed
Summary
This summary is machine-generated.

Gabapentin can cause encephalopathy, a brain dysfunction. This report details a rare case of gabapentin-induced coma, highlighting the use of magnetic resonance-spectrometry for diagnosis.

Keywords:
MR-spectrometryantiepileptic drugsencephalopathygabapentin

More Related Videos

The Use of Magnetic Resonance Spectroscopy as a Tool for the Measurement of Bi-hemispheric Transcranial Electric Stimulation Effects on Primary Motor Cortex Metabolism
13:56

The Use of Magnetic Resonance Spectroscopy as a Tool for the Measurement of Bi-hemispheric Transcranial Electric Stimulation Effects on Primary Motor Cortex Metabolism

Published on: November 19, 2014

Related Experiment Videos

Last Updated: Jun 24, 2026

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

The Use of Magnetic Resonance Spectroscopy as a Tool for the Measurement of Bi-hemispheric Transcranial Electric Stimulation Effects on Primary Motor Cortex Metabolism
13:56

The Use of Magnetic Resonance Spectroscopy as a Tool for the Measurement of Bi-hemispheric Transcranial Electric Stimulation Effects on Primary Motor Cortex Metabolism

Published on: November 19, 2014

Area of Science:

  • Neurology
  • Pharmacology
  • Neuroimaging

Background:

  • Encephalopathy is a known side effect of many antiepileptic drugs.
  • Gabapentin is an antiepileptic medication.
  • Information regarding gabapentin-induced coma is scarce in medical literature.

Observation:

  • A patient presented with symptoms suggestive of encephalopathy.
  • The patient had recently been treated with gabapentin.
  • Magnetic resonance-spectrometry (MRS) was utilized as part of the diagnostic workup.

Findings:

  • The case represents the third documented instance of gabapentin-induced coma.
  • Magnetic resonance-spectrometry provided valuable data for assessing the patient's condition.
  • This finding underscores a rare but serious adverse effect of gabapentin.

Implications:

  • Clinicians should consider gabapentin-induced coma in patients presenting with unexplained encephalopathy, especially after gabapentin initiation.
  • Magnetic resonance-spectrometry may aid in the diagnosis of this rare condition.
  • Further research is warranted to understand the mechanisms and prevalence of gabapentin-induced coma.